Skip to the content
 
  • Payment Plans
  • Login for Professionals
  • English
    • Deutsch
    • Français
    • Italiano
    • English
  • Healthy Travelling
  • Countries
  • News
  • Special travellers
  • Health risks
  • Vaccinations
  • Ask a specialist

MENU

  • LogIn
  • English
    • Deutsch
    • Français
    • Italiano
    • English
  • Healthy Travelling
  • Countries
  • News
  • Special travellers
  • Health risks
  • Vaccinations
  • Ask a specialist
 

Health Advice for Travellers
Swiss Expert Committee for Travel Medicine

 

Health Advice for Travellers
Swiss Expert Committee for Travel Medicine

 

Health Advice for Travellers
Swiss Expert Committee for Travel Medicine

The Democratic Republic of the Congo's (DRC) 17th Ebola outbreak, caused by the Bundibugyo virus and declared a Public Health Emergency of International Concern (PHEIC) on 17 May 2026, has been spreading across the provinces of Ituri, North Kivu, and South Kivu, with confirmed cross-border transmission into the Ugandan capital, Kampala.

 

Critical containment gaps, including insecurity and conflict, a contact follow-up rate well below the target level, infections among healthcare workers, deficiencies in infection prevention and control (IPC), and a funding shortfall, are sustaining transmission. The absence of an approved vaccine for this species of ebolavirus limits the range of available countermeasures.

 

On 2 June 2026, WHO reported that the number of suspected cases in the DRC had decreased compared to previous reports after many were ruled out through investigation and testing. This decline reflects case reclassification rather than necessarily reduced transmission.

 

D.R. Congo: data as of 04 June 2026 (for updates see WHO dashboard and ECDC):

  • Cases: 379 confirmed and 303 suspected cases.
    Confirmed cases have been reported from Ituri (> 340 confirmed cases in 17 health zones), North Kivu (19 confirmed cases in seven health zones) and South Kivu provinces (three cases from one health zone),
  • Deaths: 63 confirmed and 259 suspected deaths.
  • Active cases: 238 confirmed cases.
  • Recoveries: 6 cases.
  • Contacts: The overall contact follow-up rate in the DRC was 43.6%, below the operational target of 95%. 
  • Operational update: Bunia airport in Ituri Province reopened after a previous suspension of passenger flights. Screening measures have been put in place.
  • Operational challenges:
    • Information regarding transmission chains and affected population groups is currently limited, partly due to the complex context of ongoing insecurity and humanitarian challenges in the affected areas.

 

Uganda: data as of 04 June 2026 (for updates see WHO dashboard and ECDC):

  • Cases, deaths: a total of 16 confirmed cases, including one death have been reported.
  • Location: At least seven cases were associated with local transmission events and four with travel links to DRC, according to health officials. Of nine cases with known geographical information, eight cases were reported in Kampala, except one case that was reported in the neighbouring district of Wakiso. Three of the cases have travel links to DRC and five are contacts linked to the first two cases, including 3 healthcare workers.
  • Contacts: As of 02 June, 668 contacts have been identified and are being closely monitored / followed up.

 

Outside Africa:

  • One confirmed BVD case involving a US surgeon is still hospitalized in Berlin, Germany as well as six contacts. Another contact was to be transferred to Czechia.
  • Kenya investigated 22 Ebola alerts across nine counties, all of which tested negative. The country also strengthened surveillance, designated Ebola testing laboratories, expanded isolation capacity at national and county levels, and enhanced screening at priority points of entry.
  • Several symptomatic travellers from affected areas have been tested in EU/EEA and non-EU/EEA
    countries, all of which were negative so far.

 

Entry and exit screenings and control measures:

  • Several countries and territories reported additional border health or travel-related measures. For most UpToDate information, see IATA LINK.

 

Authorities are concerned about the risk of further spread due to population high mobility, insecurity, and the proximity of affected areas to Uganda and South Sudan through a porous border.

Distribution of suspected and confirmed Bundibugyo virus disease cases in the Democratic Republic of the Congo and Uganda, as of 6 June 2026:

 

Ebola.JPG

WHO assesses the risk of the epidemic as very high at the national level, high at regional levels, and low at the global level (including Switzerland and the EU/EEW). For details, see LINK.

ECDC assesses the risk for EU/EEA travellers in affected areas as low if precautions (see under “consequences for travelers”) are followed but emphasizes uncertainties and rapid evolution.

 

Due to the very recent declaration of the outbreak and the uncertainties related to the
epidemiological information, it is probable that the outbreak is much larger than what is currently
being reported – not only in regards to the number of affected cases, but also in its geographical extent.

 

The situation is evolving rapidly! Always stay informed before, during, and after travel! As of 11 June 2026:

  • Avoid non-essential travel to the affected areas in DRC (provinces of Ituri, North Kivu, South Kivu), and to nearby areas in neighboring countries, also due to the security situation (see EDA).
  • For travel in Uganda and the DRC outside the affected areas: Keep yourself regularly updated via official sources. Be aware that conditions can change rapidly. Access to medical care - for accidents, fever, or other health concerns - may be limited and challenging and may involve risks, as may medical evacuation.

The following precautions are recommended for all travel to the DRC and Uganda as well as in neighboring countries:

 

General preventive measures:

  • Wash hands regularly and carefully using soap and water (or alcohol gel if soap is unavailable).
  • Avoid contact with sick people who have symptoms, such as fever, muscle pain, and rash.
  • Avoid contact with blood and other body fluids.
  • Avoid visiting healthcare facilities in the affected areas for nonurgent medical care or non-medical reasons.
  • Avoid contact with dead bodies or items that have been in contact with dead bodies, participating in funeral or burial rituals, or attending a funeral or burial. 
  • Avoid handling, cooking, or eating bush/wild meat (meat of wild/feral mammals killed for food).
  • Wash and peel fruit and vegetables before consumption.
  • Avoid visiting mines or bat caves and contact with all wild animals; alive or dead, particularly bats and the great apes.
  • Practice safer sex.
  • Stay informed for entry and exit requirements by countries, see IATA LINK.
  • If you feel unwell during flight, inform crew immediately and avoid close physical contact with other passengers.

Of note: there is currently no licensed vaccine or specific treatment against Ebola diseased caused by Bundibugyo virus. For humanitarian missions, consultation with a travel medicine specialist is recommended.

 

 

While in the affected areas in DRC and in Uganda and for 21 days after leaving:
  • Watch for symptoms (see below).
  • Expect health screening at departure.
  • Stay reachable if contacted by health authorities.
  • Follow quarantine measures established by your local health authorities.

 

! In case of symptoms headache, body aches, muscle pain, fatigue, loss of appetite, vomiting or diarrhea during your stay in and for 21 days after leaving north-eastern D.R. Congo (province of Ituri, North Kivu, South Kivu) and /or Uganda, especially the affected areas:

  • Separate yourself from others (isolate) immediately.
  • Do not travel.
  • By phone: contact local health authorities or a healthcare facility for a thorough evaluation of your risk (e.g. tropical institute or travel clinic or university hospital infectious disease unit).
  • Always state that you were in the affected areas and you may have had a possible exposure to Ebola (incubation period: 2-21 days). 
  • While under investigation as a suspected case, please also raise the issue of a malaria test and other investigations.
  • Details for Ebola disease: see BAG and RKI (in German) or ECDC (in English).

Recommendations of the Swiss Expert Committee for Travel Medicine (as of 11 June 2026, subject to change according to the evolving situation):
A suspected case is:

  1. A symptomatic person (see FOPH case definition) with a history of stay within the last 21 days in north-eastern D.R. Congo (province of Ituri, North Kivu, South Kivu) and/or Uganda. 
                              AND
  2. Having had a high-risk exposure* - evaluated by a specialist in tropical medicine or infectious diseases (in case of doubt, contact the Geneva Reference Centre for Emerging Virus Diseases).

Such cases should be isolated, tested, and reported to the Cantonal Physician and the Swiss Federal Office of Public Health within 2 hours.

 

*High-risk exposure includes:

  • Participation in local funerals; or
  • Contact with a sick patient, their body fluids, and/or contaminated material, at home, during transport, or in a healthcare facility; or
  • Attendance at a local healthcare facility.
  • Direct contact with bats, rodents, non-human primates, living or dead, in or from Ebola disease affected areas, or bushmeat.
  • Having unprotected sexual contact with a case up to six months after recovery.
 
WHO Ebola Portal, accessed 3.6.2026 | ECDC, accessed 3.6.2026 | WHO DON, 29.5.2026 | Reuters, 2.6.2026 | Via BEACON, 4.6.2026

Between January and mid-April 2026, Zimbabwe reported 65’399 malaria cases and 174 deaths, nearly double the number of cases reported during the same period in 2025 (around 36'000) and almost four times the 2024 total (around 17’000). The outbreak has affected multiple districts across Manicaland, Mashonaland Central, Mashonaland East, and Mashonaland West, including areas previously nearing elimination.

 

Similar increases are being observed across other countries in Southern Africa Region. The surge has been linked to heavy rainfall during the 2025–2026 season, which created favorable mosquito-breeding.

 

Meteorological forecasts predict increased rainfall across southern African countries in the upcoming months. Given the already high malaria case numbers from January to May 2026 in Namibia, Botswana, and Zimbabwe, it is possible that these countries will face heightened malaria risk from June to August, even in areas where risk is typically moderate during these months. 

Optimal mosquito protection 24/7 (at dusk and at night against malaria, during the day against other arboviruses).

 

Malaria chemoprophylaxis is recommended, including during the usually moderate transmission period from June to August in seasonal risk areas, given the recent increase in malaria cases and the forecasted increased precipitations in the upcoming months and favorable conditions for mosquito breeding. 

WMO, 21.5.2026 | Via BEACON, 7.6.2026
The Pan American Health Organization (PAHO) has published Public Health Recommendations for travelers attending the 2026 FIFA World Cup.
See also recommendation in the EpiNews as of 15.5.2026.
PAHO, 4.6.2026

A man from Ramanattukara, Kozhikode, Kerala, was tested positive for Nipah on 11 June 2026. The patient is in critical condition. The infection is suspected to be linked to bat exposure while cleaning a storage facility. A total of 77 contacts have been identified.

 

Nipah virus outbreaks have been reported previously in Kerala and other states of India.

Follow official and media reports. Follow local instructions.

 

Avoid contact with sick persons and animals (bats) and avoid contact with their excreta. Avoid consumption of raw fruit juices and unwashed, especially bitten, tree fruits or vegetables. Consult a doctor if symptoms appear. There is neither a vaccination for humans nor a specific treatment.

Via BEACON, 10.6.2026

Get in touch with us

  • Sekretariat Schweizerische Fachgesellschaft für Tropen- und Reisemedizin,
    Socinstrasse 55, Postfach, 4002 Basel

  • info@healthytravel.ch
  • Ask a specialist
  • News
  • Contact
  • Payment Plans
  • Sponsors
  • Legal notice

Copyright © 2026. All Rights Reserved

0

Bookmarks